- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01542164
Calcium Intake and Fat Excretion (KIFU/B266)
Calcium Intake and Fat Excretion - an Observational Study
Study Overview
Status
Conditions
Detailed Description
Several reports have found inverse associations between calcium intake and body weight. Few intervention studies have shown that a high calcium diet resulted in a greater body weight loss than a low calcium diet. The mechanism is not clear, but one possible explanation is reduced absorption of fat in the gut, due to formation of insoluble calcium fatty acid soaps or binding of bile acids which impairs the formation of micelles.
The aim of this study is to examined for an association between habitual calcium intake and fecal energy and fat excretion, concentrations of substrates involved in energy metabolism, blood pressure and body weight
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Frederiksberg, Copenhagen, Denmark, 1958
- Dept. of Human Nutrition, Faculty of Life Sciences, University of Copenhagen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- age between 18 - 50 years
- healthy
- weight stable within 4 months prior to the inclusion
Exclusion Criteria:
- pregnant or lactating
- uses cholesterol lowering drugs
- on diet
- suffering from, now or previously, any gastrointestinal diseases
- elite athletes
- participation in other concomitant trial
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total fat and energy excretion
Time Frame: 5 days
|
Total fat and energy excretion in faeces during the test period of 5 consecutive days
|
5 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
p-vitamin D
Time Frame: 1 day
|
1 day
|
|
|
p-PTH
Time Frame: 1 day
|
Parathyroid hormone (PTH)
|
1 day
|
|
Selected genetic variations
Time Frame: 1 day
|
DNA from blood sample
|
1 day
|
|
Blood lipids and cholesterol
Time Frame: 1 day
|
Total p-cholesterol, p-LDL, p-HDL, p-TG and p-FFA
|
1 day
|
|
calcium excretion
Time Frame: 2 days
|
Total calcium excretion in faeces and urin during the test period of 2 consecutive days
|
2 days
|
|
Gut micro flora
Time Frame: 1 day
|
Identification of gut micro flora
|
1 day
|
|
NMR-spectroscopy based metabonomics profiling of urin
Time Frame: 1 day
|
NMR-spectroscopy based metabonomics profiling of each test subject
|
1 day
|
|
blood pressure
Time Frame: 1 day
|
Resting blood pressure
|
1 day
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Lesli H. Larsen, Ass. Prof., Dept. of Human Nutrition, Faculty of Life Sciences, Univerity of Copenhagen
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- H-B-2009-071
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.